galantamine has been researched along with Syncope in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Ahuja, M; Gabor, C; Karimi, A; Lee, J; Lewis, K; Patterson, C; Reppas-Rindlisbacher, C; Siddhpuria, S; Sood, E; Wong, E | 1 |
| Berkers, M; Carmichael, PH; Egberts, T; Kröger, E; Souverein, P; van Marum, R | 1 |
| Davis, MW; Fisher, AA | 1 |
1 review(s) available for galantamine and Syncope
| Article | Year |
|---|---|
Cholinesterase inhibitors and falls, syncope and injuries in patients with cognitive impairment: a systematic review and meta-analysis.
Topics: Accidental Falls; Accidental Injuries; Cholinesterase Inhibitors; Cognitive Dysfunction; Donepezil; Fractures, Bone; Galantamine; Humans; Rivastigmine; Syncope | 2023 |
2 other study(ies) available for galantamine and Syncope
| Article | Year |
|---|---|
Use of rivastigmine or galantamine and risk of adverse cardiac events: a database study from the Netherlands.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Atrioventricular Block; Cholinesterase Inhibitors; Cohort Studies; Cross-Over Studies; Databases, Factual; Female; Galantamine; Hospitalization; Humans; Incidence; Male; Netherlands; Phenylcarbamates; Poisson Distribution; Proportional Hazards Models; Risk; Rivastigmine; Syncope | 2012 |
Prolonged QT interval, syncope, and delirium with galantamine.
Topics: Aged, 80 and over; Delirium; Galantamine; Humans; Long QT Syndrome; Male; Syncope | 2008 |